Radyus Research

At Radyus, we are a drug development organization built by seasoned experts in pharma R&D and venture capital. We know what success looks like to buyers and investors - and we help our clients achieve it faster. We partner with global biotech companies and investment groups to drive value creation from lead optimization through IND-enabling studies and into first-in-human trials. Our team brings deep therapeutic expertise in immunology, oncology, infectious diseases, metabolic diseases, and neurosciences, across therapeutic modalities. We operate as embedded partners, managing your drug development program from candidate selection through clinical proof of concept (PoC), including: • Product development planning • Budget, timelines, and milestone planning • Preclinical efficacy and safety studies • Fully-integrated program management • Vendor selection and management • IND-enabling study design and oversight • CMC strategy and manufacturing planning • Regulatory strategy and FDA filings • Clinical trial design and operations Whether you are building your first program or scaling your portfolio, Radyus integrates strategic consulting, project management, experimental support, and clinical operations to deliver investor-ready milestones and accelerate your path to success.